Tiziana Life Sciences announced the appointment of Professor Roberto Pellicciari to the company's Scientific Advisory Board and as a consultant to the company. Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals Inc. Professor Pellicciari is presently Professor of Medicinal Chemistry at the University of Perugia in Italy and has held a number of prestigious scientific posts.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8052 USD | -0.35% |
|
-1.86% | +43.79% |
Jun. 28 | Tiziana Life Sciences Gets $3.4 Million in Funding for Neurodegenerative Disease Studies | MT |
Jun. 28 | Transcript : Tiziana Life Sciences Ltd - Special Call |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.79% | 81.74M | |
+22.15% | 46.56B | |
+45.26% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Appoints Roberto Pellicciari to the Scientific Advisory Board